En conclusin, la seleccin depende de una valoracin clnica completa
In general, the goal is to keep injections about one week apart to ensure steady effectiveness and minimise side effects
GLP-1 weight loss injections are typically recommended for individuals who: Have a Body Mass Index (BMI) of 30 or higher (obesity) or a BMI of 27 or higher with an obesity-related condition (like type 2 diabetes, hypertension, or high cholesterol), have difficulty losing weight through diet and exercise alone, have type 2 diabetes and need better blood sugar control along with weight management
GLP-1s are unlikely to deliver therapeutic value when so many individuals stop treatment after two years, but the findings also illustrate the need for obesity care management programs to improve adherence," David Lassen, chief clinical officer at Prime/MRx, said in a news release
For individuals living with complex, chronic conditions like Long COVID, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and dysautonomia, the daily reality is often defined by a profound, unyielding lack of energy
:format(webp))
